Search Results - "Protti, Giulia"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    A primer on single-cell RNA-seq analysis using dendritic cells as a case study by Protti, Giulia, Spreafico, Roberto

    Published in FEBS letters (08-09-2024)
    “…Recent advances in single-cell (sc) transcriptomics have revolutionized our understanding of dendritic cells (DCs), pivotal players of the immune system…”
    Get full text
    Journal Article
  3. 3

    CCR4+CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis by Montico, Guendalina, Mingozzi, Francesca, Casciano, Fabio, Protti, Giulia, Gornati, Laura, Marzola, Erika, Banfi, Giuseppe, Guerrini, Remo, Secchiero, Paola, Volinia, Stefano, Granucci, Francesca, Reali, Eva

    Published in European journal of immunology (01-04-2023)
    “…Psoriasis is a chronic inflammatory skin disease with an autoimmune component and associated with joint inflammation in up to 30% of cases. To investigate…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Abstract LB-B13: Lurbinectedin down-regulates ASCL1 transcription factor in Small Cell Lung Cancer (SCLC) by Mannarino, Laura, Craparotta, Ilaria, Mirimao, Federica, Panini, Nicolò, Lupi, Monica, Protti, Giulia, Frapolli, Roberta, Marchini, Sergio, D'Incalci, Maurizio

    Published in Molecular cancer therapeutics (01-12-2019)
    “…Abstract The reported clinical activity of lurbinectedin in Small Cell Lung Cancer (SCLC) prompted us to investigate the selective mechanism of this drug in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Abstract 3: Multiomics analyses reveal functional DNA, methylation pattern changes in clinical transgenic T-cell receptor cell therapy products by Protti, Giulia, Peters, Cole, Kawakami, Moe, Kidd, Conner, Subramanyam, Varsha, Lechien, Analynn, Dinh, Andrew, Ribas, Antoni, Pellegrini, Matteo, Nowicki, Theodore S.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Background: Transgenic T-cell receptor T-cells (TCR-T) directed against tumor-specific antigens are associated with robust initial clinical responses…”
    Get full text
    Journal Article